VanEck Pharmaceutical ETF
114 hedge funds and large institutions have $510M invested in VanEck Pharmaceutical ETF in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
10.68% more ownership
Funds ownership: 77.18% → 87.87% (+11%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
16% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 25
Holders
114
Holding in Top 10
2
Calls
$3.29M
Puts
$412K
Top Buyers
| 1 | +$26.7M | |
| 2 | +$16.7M | |
| 3 | +$11.8M | |
| 4 |
VAS
Valicenti Advisory Services
Elmira,
New York
|
+$5.59M |
| 5 |
AF
Alerus Financial
Grand Forks,
North Dakota
|
+$3.69M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$9.41M | |
| 3 | -$7.57M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.48M |
| 5 |
HF
HRT Financial
New York
|
-$3.18M |